Inmode Ltd

Inmode Ltd

INMD

Get informed when a big investor buys or sells

+ Follow
Market Cap$865.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Inmode LtdInmode Ltd12-12%2.5-
$19.00

Target Price by Analysts

26.8% upsideInmode Target Price DetailsTarget Price
$37.29

Current Fair Value

148.8% upside

Undervalued by 148.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$865.66 Million
Enterprise Value$489.39 Million
Dividend Yield$- (-)
Earnings per Share$1.45
Beta1.87
Outstanding Shares58,903,000

Return

Return on Equity12.32%ROE
Return on Assets10.76%
Return on Invested Capital12.36%

Valuation & Multiples

P/E Ratio12.05P/E Ratio
PEG-33.29PEG
Price to Sales2.5Price to Sales
Price to Book Ratio1.5Price to Book Ratio
Enterprise Value to Revenue1.31
Enterprise Value to EBIT6.18
Enterprise Value to Net Income6
Total Debt to Enterprise0.04
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$0.35
Average shareholder expectation
Revenue Estimate
$93.70 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.32
Average shareholder expectation
Revenue Estimate
$91.58 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio2.1573 10.04%
Total Calls455,900 24.05%
Total Puts983,500 30.11%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %49.55% 2.32%
Total Invested$698.99M 52.46%
Investors Holding201 1.00%

ESG Score

No data

About Inmode Ltd

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...